for Dec 21, 2019 through Dec 27, 2019
🚨 My latest #Zika research is out today in Lancet Infectious Diseases!🚨
— F🌲🎁st🎅 B🎁st🎅s (@FaustoBustos) December 21, 2019
Paper: https://t.co/4sIEbvetZl
Commentary: https://t.co/ZOL7L0ukVc
TL;DR: Zika, as a disease, is not what we think it is
There's lots of minor analyses, but I'll be going through the main argument
1/24 pic.twitter.com/TXSfdIfISC
Our approach to pathogens and infectious diseases is getting transformed by genome sequencing, as adeptly ★ reviewed here
— Eric Topol (@EricTopol) December 25, 2019
https://t.co/gpYTWsPYBZ @NEJM By @CDC_NCEZID @CDC_AMD @CDCgov Greg Armstrong, @martagwinn @dmaccannell and their colleagues #genomics pic.twitter.com/O68TpF1V4p
NEW🔥🔥#JACnews @AntonPeleg
— Antibiotic Steward 🆔 (@ABsteward) December 24, 2019
Impact of bacterial species and baseline resistance on fosfomycin efficacy in urinary tract infections. #IDTwitter ENJOY https://t.co/rtiOenyVqE pic.twitter.com/V5U2LcEZYE
Check out this commentary in @ICHEJournal by @SIDPharm members @The_Real_LDA & @aprildyerid and friend @rebsmoe describing the "Do's" and "Don'ts" of Antibiotic Electronic Order and Progress Note Documentation!
— SIDP (@SIDPharm) December 23, 2019
Full article here: https://t.co/EXFt1dUCmY#IDTwitter #Stewardship pic.twitter.com/oify5bzjPf
WHO just admitted it.
— Neville Raymond (@epochchanger) December 27, 2019
Clean water outperforms #vaccines in reducing infectious diseases.
Then shouldn't the discovery of clean water be an even greater milestone of medicine than vaccines?
And if we drink it all the time, why do we need vaccines?https://t.co/yjsjjZzFV5
NEW 🔥 in AAC @ASMicrobiology
— Antibiotic Steward 🆔 (@ABsteward) December 23, 2019
Taniborbactam a new cyclic boronate broad-spectrum inhibitor of serine- & metallo-β-lactamases, restores activity of cefepime in Enterobacterales & Psedomonas aeruginosa. #IDTwitter https://t.co/9Nr0uTOeqo
NEW🔥 in OFID @id_seval @DrEllenEaton @SandySpringerMD
— Antibiotic Steward 🆔 (@ABsteward) December 24, 2019
Beyond Antibiotics: A Practical Guide for The Infectious Disease Physician to Treat Opioid Use Disorder in the Setting of Associated Infectious Diseases. @serotavirus @PaulSaxMD @IDSAInfo #IDTwitter https://t.co/daYJG2PTc2
🔥🎆🎄🆔🔔
— Antibiotic Steward 🆔 (@ABsteward) December 26, 2019
NEJM Journal Watch Infectious Diseases Top Stories of 2019.
Featuring OVIVA POET FQs PrEP ART weight gain #IDTwitter #medtwitter https://t.co/IrT0igjP2p pic.twitter.com/cZuzBwzIdu
In this article on the @GlobalHealthBMJ BMJ Global Health Blog, I write about the importance of applying Implementation Science to improve antimicrobial stewardship (AMS) in all healthcare settings.https://t.co/ahxlewjbkM#ImplementationScience #AMS #LMICs #GlobalHealth pic.twitter.com/c7tCZmhksc
— Ayodeji Matuluko (@AyodejiMatuluko) December 22, 2019
People using illicit opioids are not only at an increased risk of a drug-related death, but a new study finds they have an elevated risk of dying from noncommunicable diseases, infectious diseases, suicide and unintentional injuries https://t.co/8IR4GlTuFO
— CNN (@CNN) December 26, 2019
People using illicit opioids are not only at an increased risk of a drug-related death, but a new study finds they have an elevated risk of dying from noncommunicable diseases, infectious diseases, suicide and unintentional injuries https://t.co/BSiTnDFXKf
— CNN (@CNN) December 27, 2019
Retrospective multi-center study, but these data certainly add to the existing evidence suggesting shorter courses are just as effective as longer courses for common infections!
— SIDP (@SIDPharm) December 22, 2019
Full article here: https://t.co/4Q7vJFb2zM #IDTwitter pic.twitter.com/icjRVjez80
Day #1: The famous STOP-IT trial, showing that 4 days of abx Rx for abdominal collections WITH SOURCE CONTROL is non-inferior to 8 days. Entry criteria limit applicability for the #IDtwitter world ... don't think I've ever been consulted on such a case! https://t.co/gHkDb80QFn
— Paul Sax (@PaulSaxMD) December 25, 2019
Interesting! ✨✨
— Antibiotic Steward 🆔 (@ABsteward) December 23, 2019
Candida albicans enhances meropenem tolerance of Pseudomonas aeruginosa in a dual-species biofilm. #JACnews #IDTwitter https://t.co/JndxSNy34B pic.twitter.com/EMGvacI6nz
🎄 🔥 🎄 A primer on bacteriophages and bacteriophage-antibiotic combinations just published in @PharmacoJournal by @TayMorrisette @Et2955Keb @IDpharmresearch https://t.co/6yMaUOBXXN
— SIDP (@SIDPharm) December 26, 2019
Genomic analysis of carbapenemase-producing Enterobacteriaceae in Queensland reveals widespread transmission of blaIMP-4 on an IncHI2 plasmid | Microbiology Society https://t.co/3jEsnJCsEx @Loolibear @beatsonlab @UQMedicine @UQ_News @davidantibiotic @fordebm @AmyVJennison
— Patrick Harris (@padstamundo) December 24, 2019
Scientists have tended to focus on hospitals as places where “superbugs” can arise.
— Microbes&Infection (@MicrobesInfect) December 21, 2019
But in new study, #airplane sewage E. coli far surpassed #antibioticresistance reported for microbes sampled in German hospitals.https://t.co/Ta3Ek13sLt pic.twitter.com/5zrmorjuxA
Happy holidays 🎆 on @ABsteward style
— Antibiotic Steward 🆔 (@ABsteward) December 25, 2019
Are Bacteria Sensitive or Susceptible? A Micro-Comic Strip @JClinMicro #IDTwitter #medtwitter https://t.co/0SLYIspYMM pic.twitter.com/SFpMN7Adn6
Great review by @IDstewardship of the Top Infectious Diseases articles published in 2019! #IDtwitter
— Duke Raleigh Antimicrobial Stewardship (@AbxDukeRaleigh) December 22, 2019
Follow the link here: https://t.co/JzakP9FP6b via @shareaholic
While I love the attention that these types of articles bring to the major crisis in antibiotic R&D, the portrayal of hospital pharmacists blocking access to new abx is misleading (1/2) https://t.co/2IiEuJTkYZ
— Emily Heil (@emilylheil) December 26, 2019
Why isn't there a vaccine for #Staphylococcus aureus?
— Microbes&Infection (@MicrobesInfect) December 25, 2019
New research in mice found that T cells play a critical role in protecting against staph bacteria. Most vaccines rely solely on stimulating B cells.https://t.co/ODOXPZpwfQ #MRSA pic.twitter.com/IKv91XCMCU
Just published: Circulation of non-polio #enteroviruses in 24 EU and EEA countries between 2015 and 2017: a retrospective surveillance study https://t.co/WV71wUPmQD
— The Lancet Infectious Diseases (@TheLancetInfDis) December 21, 2019
New podcast from @IDSAInfo on promoting #AntimicrobialStewardship in human medicine https://t.co/wSlxONtWqW #BeAntibioticsAware #AntibioticSmart pic.twitter.com/cy6Wlv0TKi
— NFID (@NFIDvaccines) December 26, 2019
NEW 🇫🇷🔥RCT in CID
— Antibiotic Steward 🆔 (@ABsteward) December 23, 2019
Weekly sequential antibioprophylaxis for recurrent UTI among patients with neurogenic bladder using CISC. #IDTwitter
Small sample size ⚠️ https://t.co/F307GGm7OZ pic.twitter.com/hheLmrmu3f
Increasing duration of antimicrobial prophylaxis was associated with higher odds of AKI and C difficile infection in a duration-dependent fashion; extended duration did not lead to additional SSI reduction.#antimicrobialstewardship https://t.co/GB0PxKmDS1
— Syamhanin Adnan (@SyamhaninA) December 22, 2019
NEW🔥
— Antibiotic Steward 🆔 (@ABsteward) December 27, 2019
The DIAMOND Study is Published in CID : the efficacy and safety of Symtuza, a once-daily, single-tablet regimen containing (D/C/F/TAF) in a Rapid Initiation Model of Care for HIV-1 Infection. #IDTwitter https://t.co/CYwwgio84c pic.twitter.com/aAwyvFok4A
Congratulations to all recipients of the Pfizer-ISID research awards for #AntimicrobialStewardship programs in Latin American Countries! Looking forward to fantastic results @ISID_org @ProMED_mail @reactgroup @CIDRAP_ASP https://t.co/0M8ABJz1t0
— Marc Mendelson (@SouthAfricanASP) December 23, 2019
Infographic: Immunity Isn't the Body's Only Defense System.
— Microbes&Infection (@MicrobesInfect) December 25, 2019
Symbiotic bacteria, #metabolism & #stress pathways can all help animals tolerate, rather than succumb, to disease.https://t.co/dqfEBjnDuD #infectiousdisease #infection #symbiosis pic.twitter.com/XEilNB19Hx
Breaking news 🔊🔥GlaxoSmithKline's HIV drugs division ViiV Healthcare said on Saturday that the @US_FDA U.S. declined to approve its long acting HIV injection cabotegravir and rilpivirine. @PaulSaxMD @CarlosdelRio7#IDTwitter https://t.co/BKanPdRucJ
— Antibiotic Steward 🆔 (@ABsteward) December 21, 2019
"Like I said, just when we think that we’re good, we have just a little more to go. So, the new buzzword for antimicrobial stewardship is the 'outpatient stewardship' aspect of it."
— Pharmacy Times (@Pharmacy_Times) December 21, 2019
Watch Kruitka Mediwala talk about Antimicrobial Stewardships at #ASHP19: https://t.co/ayNvdDzbto pic.twitter.com/IahDxTUJjZ
Common medical or health-related words never used by doctors when talking with other doctors.
— Paul Sax (@PaulSaxMD) December 24, 2019
I'll start -- "germs" -- which shows up multiple times in this fascinating @nytimes piece on drug-resistant BACTERIA in the Ganges. https://t.co/d48PoJBqYk pic.twitter.com/FTCQfPExl7
Antimicrobial Stewardship in Hematological Patients at the intensive care unit: a global cross-sectional survey from the Nine-i Investigators Network. - PubMed - NCBI https://t.co/oOPlI4MqYR
— Jordi Rello, MD, PhD (@drjordirello) December 24, 2019
OFID: The accuracy of a new rapid urine test for #tuberculosis in people with #HIV suggests potential to improve early #TB detection and treatment in outpatients, and ultimately, reduce morbidity and mortality. https://t.co/UP7ZThbN9J #OpenForumInfectDis #IDSAJournals @PaulSaxMD
— IDSA (@IDSAInfo) December 24, 2019
Meet Meredith, a cancer survivor who passed away from an antibiotic-resistant infection. https://t.co/pRVTbHAWhM
— IDSA (@IDSAInfo) December 27, 2019
Help us spread awareness & support for the DISARM Act by contacting your legislators: https://t.co/6qJbMIjNQZ #DISARMSuperbugs pic.twitter.com/ArYINlHEiX
Receptor for bat influenza virus uncovers potential risk to humans.
— Microbes&Infection (@MicrobesInfect) December 26, 2019
How bat flu viruses infect cells has been unclear. The discovery that they bind to cell receptor that is present in different species raises concerns about their potential risk to humanshttps://t.co/1I3Nr6Ia9U pic.twitter.com/YIX8vams5w
'Antibiotic administration by subcutaneous (SC) injection is common practice in French geriatric wards as an alternative to the intravenous (IV) route, but few pharmacokinetic/pharmacodynamic data are available' #JACNews https://t.co/7WLKJ4UFPi
— BSAC (@BSACandJAC) December 23, 2019
2019 Year in review
— Antibiotic Steward 🆔 (@ABsteward) December 23, 2019
44 Novel Drugs @US_FDA Approved in 2019
4 antibiotics
July : Recarbrio: imipenem, cilastatin, relebactam
August :
Pretomanid
Xenleta :Lefamulin
November :FeTroja : Cefiderocol
The pipeline is drying up! #IDTwitter #medtwitter https://t.co/V3OFSYESqm
Day #2: Varicella pneumonia is the most common complication of varicella during pregnancy. While still a potentially severe disease warranting Rx, this cohort study demonstrated a lower incidence (2.5%) and a better prognosis than earlier estimates. https://t.co/HzhoSoU916
— Paul Sax (@PaulSaxMD) December 25, 2019
New Review: New WHO guidelines for treatment of gambiense human African #trypanosomiasis including fexinidazole: substantial changes for clinical practice https://t.co/5nQmSiwK2a #sleepingsickness
— The Lancet Infectious Diseases (@TheLancetInfDis) December 24, 2019
This is from a WHO bulletin:
— Neville Raymond (@epochchanger) December 27, 2019
"Vaccination has greatly reduced the burden of infectious diseases.
Only clean water, also considered to be a basic human right, PERFORMS BETTER."
How did WHO quantify the truth of this statement?
And does Bill Gates know?https://t.co/3eC2XHu1PB
I love a good study attempting to put a number to something we all know and have seen clinically but is difficult to quantify anecdotally. Also, a 75% increase is a lot 😫def a need for some diagnostic stewardship here @BrianHoff_ https://t.co/AQ6qACTifb
— Eric Wenzler (@TheIDApprentice) December 23, 2019
"You’d never tell a cancer patient, ‘Why don’t you try a 1950s drug first & if doesn’t work, we’ll move on to one from the 1980s"
— Antibiotic Steward 🆔 (@ABsteward) December 27, 2019
“We do this with antibiotics & it’s really having an adverse effect on patients and the marketplace“ @koutterson #IDTwitter https://t.co/azUnTe2Exk
Great review of approach to treatment of Carbapenem-Resistant Enterobacteriaceae in children by @CHOP_ID’s @KatieChiotos @hayes_m31 @jeffreysgerber and @HopkinsMedicine’s @pranita_tamma https://t.co/3x2BK1Z7BJ
— Kevin Downes (@KevinJDownes) December 24, 2019
Bacteria become resistant to antibiotics; individual people and animals do not https://t.co/0UV9kQtbtz
— Save Antibiotics (@saveantibiotics) December 22, 2019
See Now my ASP session of #Antimicrobial_Stewardship Quantitative Vs. Qualitative Metrics in FADIC 2019 Annual Meeting, from this #link below https://t.co/yQnAWQiGye@accpinfdprn @SIDPharm @idpharmd @DrDianeAshiru @CIDRAP_ASP @FADIC_DIC @WHO @CDCgov #AMR #FADICAM2019 pic.twitter.com/OfqFs2HRkX
— Rasha Abdelsalam (@salam_rasha) December 24, 2019
#Highlighted Article -#Metformin promotes Mycobacterium #tuberculosis killing and increases the production of human β-defensins in lung epithelial cells and macrophageshttps://t.co/UwCvclHOkX #openaccess #diabetes #TB #immunology pic.twitter.com/gLYnFj1SYr
— Microbes&Infection (@MicrobesInfect) December 27, 2019
Excited that our team from @CAAR_Aus will attending #ICID2020 @ISID_org, presenting new #penicillinallergy data in “hot topics” session & hosting 💊 Antibiotic Allergy in Practice Workshop- limited places so register! https://t.co/U9W4MuTZCf @id_austin @UniMelbMDHS @Austin_Health https://t.co/DyZEjFnRpe
— Jason Trubiano 🆔 (@TrubianoJason) December 26, 2019
Vets! There’s still time to join our #FREE Antimicrobial Stewardship in Veterinary medicine course: https://t.co/pQkiuiGkth @UniOfSurrey @SurreyVet @TheDickVet @NottinghamVets @Bristol_AMR @Bristol_Vets @LivUniVets @RoyalVetCollege @CamVetSchool @ucdvetmed @Reyher_UofBVet
— BSAC (@BSACandJAC) December 23, 2019
A last-ditch weapon against deadly antibiotic-resistance "superbug" pathogens
— Yoni Maisel (@Primary_Immune) December 26, 2019
- The hope, promise (and inspiration) of "Phage Therapy" https://t.co/iGMtluPuJQ #serverless #bigdata #IoT #snrtg #scicomm #antibioticresistance #Infectiousdiseases #technology #biotech #immunology pic.twitter.com/LOZVRcL3J9
Scientists in Seattle are scrambling to find new homes for research into tuberculosis vaccines and other treatments for neglected diseases after their employer, the Infectious Disease Research Institute, abruptly shut down their programs. https://t.co/hcsT1EcArj
— NYT Science (@NYTScience) December 22, 2019
Clinical and Economic Benefits of Antimicrobial Stewardship Programs in Hemodialysis Facilities: A Decision Analytic Model. https://t.co/xKl2P0C4hz
— AntibioticResistance (@AntibioticResis) December 26, 2019
Created by Cameron Forbes. Last updated January 18, 2020 at 05:08 EST.